Podcast #3: Doing Digital Deals in Life Sciences | Defining & Valuing the Asset
Pharmaceutical Technology
JUNE 6, 2024
In this series, life sciences industry M&A veteran John Easton will discuss how digital deals differ from traditional life science deals
Let's personalize your content